Ce n’est pas la première équipe à le dire : un ratio plus élevé de protéines végétales par rapport aux protéines animales permet d’améliorer significativement la santé cardiaque. Cette large étude lon ...

Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest GenesisX robotic system is being featured for the first time at ...

Cepham is increasing its commitment to men’s health during the holiday season when men typically face more health challenges. The American Heart Association highlights that winter weather and holiday ...

Seegnal’s innovative system, developed in Israel, serves as a "virtual pharmacist," supporting medication management and clinical decision-making in hospitals and clinics. By being listed on the ...

This growing partnership supports Gelteq’s strategic push into the U.S. market following the recent hiring of Adam Bendell as the Company’s U.S. President and the establishment of a U.S.-based office.

TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce the appointment of Annesley Wallace as the new President & Chief Executive Officer (CEO ...

The partnership underscores the importance of collaboration in addressing the diverse requirements of healthcare AI development. By integrating OneMedNet's robust iRWDä platform with Bayer's AIIP, ...

Mapi is actively seeking new partnership opportunities for its proprietary Depot products. Company management will be available for one-on-one meetings during the HealthCONx Conference to discuss ...

Nantes, France, le 2 décembre 2024, 18 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce aujourd’hui le renforcement de son équipe de direction et de son Comité exécutif ave ...

Now, Spectral AI is expanding its focus to emergency departments, where the stakes are equally high. The truthing process will include data collected during the critical early stages of care, enabling ...

Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the Company’s stockholders at ...

Fast Track designation is designed to expedite clinical development and regulatory review timelines Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases, including ...